133 related articles for article (PubMed ID: 1929254)
1. Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
Araki H; Minami S; Watanabe Y; Yasuda T
Antimicrob Agents Chemother; 1991 Jun; 35(6):1131-6. PubMed ID: 1929254
[TBL] [Abstract][Full Text] [Related]
2. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
[TBL] [Abstract][Full Text] [Related]
3. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial antagonism of beta-lactam antibiotics in experimental infections.
Kasai K
Chemotherapy; 1986; 32(2):148-58. PubMed ID: 3516593
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Kitzis MD; Ferré B; Coutrot A; Acar JF; Gutmann L
Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
Dalhoff A; Gehl AE; Gau W; Lode H
Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
[TBL] [Abstract][Full Text] [Related]
7. Distribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch.
Arai S; Kobayashi S; Hayashi S; Sakaguchi T
Antimicrob Agents Chemother; 1988 Sep; 32(9):1396-9. PubMed ID: 3196001
[TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
9. Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.
Tsang JC; Sansing GA; Miller MA
Antimicrob Agents Chemother; 1975 Sep; 8(3):277-81. PubMed ID: 1101819
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
[TBL] [Abstract][Full Text] [Related]
11. beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens.
Farrar WE; O'dell NM
J Infect Dis; 1976 Sep; 134(3):245-51. PubMed ID: 789784
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
Saito M; Saito T; Yano K; Shibata K; Nishino T; Tanino T
J Antimicrob Chemother; 1984 Feb; 13(2):133-42. PubMed ID: 6368517
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
Minami S; Araki H; Watanabe Y; Yasuda T; Takai A; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Feb; 29(2):376-8. PubMed ID: 3521482
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.
Gianneli D; Tzelepi E; Tzouvelekis LS; Mentis AF; Nikolopoulou C
Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):764-7. PubMed ID: 7843183
[TBL] [Abstract][Full Text] [Related]
16. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
[TBL] [Abstract][Full Text] [Related]
17. beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.
Sanders CC
Antimicrob Agents Chemother; 1989 Aug; 33(8):1313-7. PubMed ID: 2802558
[TBL] [Abstract][Full Text] [Related]
18. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
[TBL] [Abstract][Full Text] [Related]
19. Clinical isolate of a Xanthomonas maltophilia strain producing L-1-deficient and L-2-inducible beta-lactamases.
Bonfiglio G; Stefani S; Nicoletti G
Chemotherapy; 1995; 41(2):121-4. PubMed ID: 7758355
[TBL] [Abstract][Full Text] [Related]
20. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.
Minami S; Yotsuji A; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Sep; 18(3):382-5. PubMed ID: 6968541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
